Skip to content

Frontlight ResearchEarly access

Trial site

Saint-Jérôme

Saint-Jérôme, J7Z 5T3, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Atrial fibrillation

Closed trials

Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200· Phase 3· Anthos Therapeutics, Inc.· Source
Contact: Anthos Therapeutics a Novartis Company

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error